Noven Pharmaceuticals (NOVN) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Noven Pharmaceuticals (NOVN)

An SI Board Since August 1997

Posts	SubjectMarks	Bans	Symbol
66	6	0	NOVN

Emcee: Todd D. Wiener	Type: Unmoderated

Introduction Market Data Compact

Noven is a leader in developing and manufacturing transdermal and transoral drug delivery systems. These systems utilize an adhesive patch containing medication which, when adhered to the skin or the mucosa of the oral cavity, allows the delivery of drugs across the tissues and into the bloodstream over an extended period of time. Noven has developed and patented thin, solid state, multi-laminate transdermal and transoral drug delivery systems that have a small surface area and are adaptable to deliver numerous drug entities.

News: biz.yahoo.com
SEC: sec.gov

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
66	ouch biz.yahoo.com	faqsnlojiks	-	4/28/2003
65	Of the women interviewed after the WHI discontinuation, 77% were aware of the ne	Mr.G	-	10/4/2002
64	Noven Pharmaceuticals, Inc. Statement of Operations Three Months Ended	Red Heeler	-	11/1/2000
63	NOVEN ANNOUNCES RECORD FINANCIAL RESULTS Net Income Up 193% Over 1999 Third Qu	Red Heeler	-	11/1/2000
62	<How seriously to take the bad sales??> GULP... today is your answer. DA	LLCF	-	10/30/2000
61	How seriously to take the bad sales?? Anyway, Cabot lists Noven as one of their	kenzo5	-	10/24/2000
60	Wow, those last two posts must have passed through a wormhole. NOVN has held up	Red Heeler	-	10/19/2000
59	Multi-year high today, maybe all-time.	Sr K	-	6/27/2000
58	Just Received Fahnestock Update Fahnestock appears to have raised their EPS e	zizzerzazzer	-	3/23/2000
57	This is test2 which will get edited:	Sr K	-	11/16/1999
56	This is a test of using fixed font.	Sr K	-	11/16/1999
55	NOVN hits an all time high yesterday on more than double average daily volume.	kendall harmon	-	11/13/1999
54	Of note on the national news today, that female hormone replacement reduces sig	tktom	-	10/31/1999
53	Did anyone else listen to the conference call regarding the Novartis/RPR transa	zizzerzazzer	-	10/5/1999
52	Fahnestock Comments - 9/24/99 Current prescription trends show steadily higer	zizzerzazzer	-	9/24/1999
51	Fahnestock Earnings Upgrade: Fahnestock raised its 1999 EPS estimate for Noven	zizzerzazzer	-	8/10/1999
50	Great Quarter & Conference Call Don't see how NOVN could have done muc	zizzerzazzer	-	8/5/1999
49	Fahnestock continues to rate as Strong Buy. <<The company is on track to	zizzerzazzer	-	7/3/1999
48	A study presented at the 81st Annual Meeting of the Endocrine Society this week	zizzerzazzer	-	6/26/1999
47	Noven's work in the past on insulin.... Dug this up on NOVN's work wit	tktom	-	6/13/1999
46	Well, at least the stock seems to have good support around 6..Even with low vo	tktom	-	6/5/1999
45	NOVN now has a great new drug in Phase I (ADS), and a great new Web site!!	tktom	-	5/27/1999
44	Noven's teleconference held this morning can be replayed between now and Ma	zizzerzazzer	-	5/5/1999
43	Ho-Hum, another excellent earnings report. First quarter $0.03 above consensus	zizzerzazzer	-	5/5/1999
42	Well, the Earnings Release May 5 or 10 should validate that NOVN is on it's	tktom	-	5/1/1999

Go to reply# or date (mm/dd/yy):